Home > Healthcare > Biotechnology > Biotechnology R&D > Direct-to-Consumer (DTC) Genetic Testing Market

Direct-to-Consumer (DTC) Genetic Testing Market Size

Report ID: GMI3033
Published Date: Jan 2023
Report Format: PDF

Download Free Sample

Direct-to-Consumer Genetic Testing Market Size

Direct-to-Consumer Genetic Testing Market size surpassed USD 3 billion in 2022 and is predicted to expand at over 11.5% CAGR from 2023-2032. Rising prevalence of genetic disorders will accelerate industry growth.

To get key market trends

Download Free Sample

A dramatic rise in the incidences of genetic disorders such as cystic fibrosis, Sickle cell disease, Alzheimer’s disease (AD), and some cancers is expected to proliferate the demand for DTC genetic tests. For instance, as per the 2022 report by the National Institute of Health (NIH), nearly 6.5 million people above 65 years of age in the U.S. have AD-related dementia and the patient pool is estimated to exceed 13.5 million by 2060 in case of a dearth in medical breakthroughs.

The increasing focus on customized healthcare solutions has fostered the substantial demand for personalized DTC genetic tests, particularly across developing countries with burgeoning medical needs. Additionally, leading industry players are implementing strategic deals to provide modern testing services on online platforms with improved accessibility. For instance, in October 2021, 23andMe announced plans to acquire Lemonaid Health, a virtual healthcare, and pharmacy platform to combine personalized genetics services and primary care.

Direct-to-Consumer Genetic Testing Market Report Attributes
Report Attribute	Details
Base Year:	2022
Direct-to-Consumer Genetic Testing Market Size in 2022:	USD 3 Billion
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	11.5%
2032 Value Projection:	USD 10.5 Billion
Historical Data for:	2018 to 2022
No. of Pages:	190
Tables, Charts & Figures:	316
Segments covered:	Test Type, Technology, Distribution Channel and Region.
Growth Drivers:	Rising public awareness regarding DTC genetic tests Rise in disposable income in emerging economies Increasing demand for personalized DTC genetic services in developed countries Growing incidences of genetic disorders globally
Pitfalls & Challenges:	High cost of DTC genetic testing Defects in the DTC testing Data privacy concerns associated with DTC genetic testing

Learn more about the key segments shaping this market

Download Free Sample

High pricing model of DTC kits may impede product demand

High costs associated with DTC genetic testing services could hamper the direct-to-consumer genetic testing market outlook. A large number of manufacturers are focusing on product innovations and integration of next-generation technologies to introduce high-end DTC tests, leading to higher product pricing. For instance, based on the complexity of the test and severity of the disease, the cost of DTC genetic tests varies from USD 100 to USD 3,000. Hence, the demand for genetic services across underdeveloped and developing regions could potentially reduce with affordability issues.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global DTC genetic testing market was worth more than USD 3 billion in 2022 and is expected to witness over 11.5% CAGR from 2023-2032.

Single nucleotide polymorphism (SNP) chips is anticipated to exhibit over 12% CAGR over 2032 driven by their ability to improve the accuracy and efficiency of advanced DTC tests.

Europe DTC genetic testing market size is slated to reach over USD 2.7 billion by 2032 led by the presence of favorable initiatives catering to patients with rare disorders.

Ancestry, Counsyl, Easy DNA, Karmagenes SA, Mapmygenome, Identigene, MyHeritage, Dante Lab, and HomeDNA are some of the major companies in the market.